Thanks to an interdisciplinary team of researchers, scientists now have a more complete understanding of one of the human body’s most vital structures, the red blood cell. Led by University of Illinois electrical and computer engineering professor Gabriel Popescu, the team developed a model that could lead to breakthroughs in screening and treatment of blood cell morphology diseases, such as malaria and sickle-cell disease. The group published its findings in the Proceedings of the National Academy of Sciences. Red blood cells (RBCs) are unique in structure – a doughnut-shaped disc full of the oxygen-carrying molecule hemoglobin that has none of the intracellular structures of other cells, not even DNA. In circulation, RBCs must contort to squeeze through capillaries half their diameter. Their flexibility and resilience come from their membrane structure, which couples a typical lipid bilayer with an underlying matrix of protein. However, knowledge of the membrane’s mechanics is very limited. “The deformability of red blood cells is their most important property,” said Popescu, also affiliated with the Beckman Institute for Advanced Science and Technology at the university. “What we wanted to find is, how does deformability relate to morphology?” The research team used a novel measurement technique called diffraction phase microscopy, which uses two beams of light where other microscopes use only one. A research team led by Gabriel Popescu used a novel measurement technique called diffraction phase microscopy to reveal the mechanics of red blood cells. (Image: G. Popescu) “One beam goes through the specimen and one beam is used as a reference,” Popescu said. “It is very, very sensitive to minute displacements in the membrane, down to the nanoscale.” RBC membrane movement can be observed through typical light microscopes, a phenomenon known as “flickering,” but Popescu’s team was able not only to see nanoscale membrane fluctuations in live cells, but also to measure them quantitatively – a first. In addition to normal cells, the team also measured two other morphologies: bumpy RBCs called echinocytes and round ones called spherocytes. They discovered that these deformed cells display less flexibility in their membranes, a finding that could provide insight into mechanics and treatment of diseases that affect RBC shape, such as malaria, sickle-cell disease and spherocytosis. With collaborators from the University of California, Los Angeles (UCLA), the group used its data to construct a new model of the RBC membrane that accounts for fluctuations and curvature, a more complete and accurate rendering than previous models that treated the membrane as a flat sheet. “Our measurements showed that a flat model could not explain the data. With this curvature model, we understand much better what is happening in the RBC,” Popescu said. “It’s really a combination of a new optical method and new theoretical model, and that is what allowed us to find some new results where the shape and deformability are coupled.” The team’s technique eventually could be used to screen for blood diseases or to screen banked blood for membrane flexibility before transfusion, since stored blood often undergoes cellular shape changes. In addition, the novel technique has important implications for researchers interested in membrane biology and dynamics, according to Catherine Best, coauthor of the paper and instructor in the University of Illinois College of Medicine. “An advantage to studying red blood cells in this way is that we can now look at the effects of chemical agents on membranes, specifically. It is very exciting. For instance, we can look at the membrane effects of alcohol, and we may learn something about tolerance to alcohol.” Because diffraction phase microscopy measures live cells without physically manipulating or damaging them, it also could be used to evaluate medications being developed to treat blood cell morphology diseases, according to Popescu. “We can study the mechanics of a single cell under different pharmacological conditions, and I think that would be ideal for testing drugs,” he said. The National Institutes of Health and the National Science Foundation funded this research, which included collaborators from the Massachusetts Institute of Technology, Harvard Medical School, the University of Colorado, Harvard University and UCLA. For more information, visit: light.ece.uiuc.edu